HEALTHPEAK PROPERTIES, INC（DOC）の決算・業績分析
HEALTHPEAK PROPERTIES, INCの2025年有価証券報告書をAI分析。売上高$604M(+6.2%)。Real Estate。
目次
HEALTHPEAK PROPERTIES, INCの2025年度 業績サマリー
HEALTHPEAK PROPERTIES, INC（証券コード: DOC）の2025年度決算・業績分析。売上高は$604M（前年比+6.2%）。純利益は$71M（前年比-70.7%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
HEALTHPEAK PROPERTIES, INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Operating income surged to $507M (102.5% margin) driven by asset sales and merger synergies (XBRL).
- Net debt reached $8.6B (7.0x EBITDA), highlighting significant leverage despite $158M in cash reserves (XBRL).
- Revenue grew 5.0% YoY to $495M, fueled by the March 2024 merger with Physicians Realty Trust (10-K).
- Net income declined 1.0% YoY to $500M, pressured by rising interest rates and cost inflation (10-K).
- Shareholder returns totaled $716M via dividends ($648M) and buybacks ($68M), with a payout ratio of 129.5% (XBRL).
HEALTHPEAK PROPERTIES, INCの売上高変化の要因
- •Total revenue reached $495M (+5.0% YoY), with historical growth accelerating from $144M in FY2020 to $495M in FY2024 (XBRL). The merger with Physicians Realty Trust and asset sales were primary growth drivers, though segment-specific revenue breakdowns are unavailable (10-K). The 5-year revenue CAGR of 29.6% reflects strong expansion, though net income CAGR has declined 22.0% YoY due to rising costs (XBRL).
HEALTHPEAK PROPERTIES, INCの営業利益変化の要因
- •Operating income of $507M (102.5% margin) and EBITDA of $1.2B (246.0% YoY growth) reflect strong asset utilization and favorable lease terms (XBRL). However, net income fell 1.0% YoY to $500M, constrained by higher interest rates and cost pressures (10-K). Operating margins remain exceptionally high, but net margins (101.1%) are nearly identical, suggesting minimal non-operating expenses or tax benefits (XBRL).
HEALTHPEAK PROPERTIES, INCの事業リスクと対応
Macroeconomic trends (inflation, interest rates) increase costs and reduce tenant demand (10-K).
Rising interest rates harm financing terms, asset values, and tenant spending (10-K).
Life science industry consolidation reduces lab property demand (10-K).
Regulatory and funding challenges for lab tenants strain rent payments (10-K).
Labor shortages and rising costs disrupt operations and increase expenses (10-K).
High net debt (7.0x EBITDA) increases vulnerability to interest rate fluctuations (XBRL).
Geopolitical risks and cost pressures from tenant improvements may impact future results (10-K).
HEALTHPEAK PROPERTIES, INCの今後の見通し・業績予想
HEALTHPEAK PROPERTIES, INCの事業内容
Healthpeak Properties, Inc. operates high-quality healthcare real estate in the U.S., generating revenue through rental income and property management services. Key segments include outpatient medical buildings, lab facilities, and continuing care retirement communities (CCRCs) via RIDEA structures. Competitive advantages include scale, industry relationships, and a strong balance sheet with staggered debt maturities (10-K). The company's growth in FY2024 was driven by the merger with Physicians Realty Trust, which added 299 outpatient buildings, and strategic asset sales (10-K).
HEALTHPEAK PROPERTIES, INCのAI業績分析レポート（2024年度）
Annual Report Analysis: Healthpeak Properties, Inc. (DOC) FY2024
Highlights
Business Overview
Healthpeak Properties, Inc. operates high-quality healthcare real estate in the U.S., generating revenue through rental income and property management services. Key segments include outpatient medical buildings, lab facilities, and continuing care retirement communities (CCRCs) via RIDEA structures. Competitive advantages include scale, industry relationships, and a strong balance sheet with staggered debt maturities (10-K). The company's growth in FY2024 was driven by the merger with Physicians Realty Trust, which added 299 outpatient buildings, and strategic asset sales (10-K).
Revenue Analysis
Total revenue reached $495M (+5.0% YoY), with historical growth accelerating from $144M in FY2020 to $495M in FY2024 (XBRL). The merger with Physicians Realty Trust and asset sales were primary growth drivers, though segment-specific revenue breakdowns are unavailable (10-K). The 5-year revenue CAGR of 29.6% reflects strong expansion, though net income CAGR has declined 22.0% YoY due to rising costs (XBRL).
Profitability Analysis
Operating income of $507M (102.5% margin) and EBITDA of $1.2B (246.0% YoY growth) reflect strong asset utilization and favorable lease terms (XBRL). However, net income fell 1.0% YoY to $500M, constrained by higher interest rates and cost pressures (10-K). Operating margins remain exceptionally high, but net margins (101.1%) are nearly identical, suggesting minimal non-operating expenses or tax benefits (XBRL).
Balance Sheet Analysis
Total assets stood at $15.7B, with equity at $6.4B (40.5% equity ratio) and long-term debt of $8.7B (D/E ratio: 1.38x) (XBRL). Net debt of $8.6B (7.0x EBITDA) underscores leverage, though cash reserves of $158M provide liquidity (XBRL). Total equity declined from $6.7B in FY2023 to $6.4B in FY2024, reflecting dividend payouts and share repurchases (XBRL).
Cash Flow Analysis
Operating cash flow reached $900M, exceeding net income of $500M (XBRL). Free cash flow was $24M, constrained by investing activities of -$876M, including $697M from asset sales and $83M in development projects (10-K). Financing activities totaled -$117M, with $648M in dividends and $68M in share repurchases (XBRL).
Working Capital Analysis
Receivables Days: 41 days (XBRL). Asset Turnover: 0.03x (XBRL). No data available for payables days or cash conversion cycle (N/A).
Risks
Outlook
Management anticipates continued challenges from rising interest rates, geopolitical risks, and cost inflation (10-K). The merger with Physicians Realty Trust and asset sales are highlighted as growth drivers, though no explicit forward-looking guidance is provided (10-K).
Historical Time Series
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | 144M | 144M | 436M | 471M | 495M | 527M |
| Operating Income | N/A | N/A | N/A | N/A | 507M | N/A |
| Net Income | 1.1B | 46M | 414M | 506M | 500M | 306M |
| Total Assets | 14.0B | 15.9B | 15.3B | 15.8B | 15.7B | 19.9B |
| Total Equity | 6.1B | 6.7B | 6.5B | 6.7B | 6.4B | 8.4B |
| Operating Cash Flow | 849M | 846M | 758M | 795M | 900M | 956M |
Real Estateの企業一覧
HEALTHPEAK PROPERTIES, INCと同じ「Real Estate」セクターの企業